Advertisement

Topics

Latest Pharmacy NewsRSS

23:02 EST 21st November 2017 | BioPortfolio

Renhe Pharmacy Co Ltd 000650 Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryRenhe Pharmacy Co Ltd Renhe Pharmacy is a manufacturer and distributor of Chinese and Western medicine, API, and health related products. The company provides products in the form of oral solid preparations, oral liquid preparations, large capacity injection, small volume injection, topical lotions, liniments, suppositories, ointments and other dosage forms of health related products. Its p...

FDA Approves First Two-Drug Regimen For Certain Patients With HIV

NewsFDA approved Juluca, the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 (HIV-1).

STAT Plus: Not a Dutch treat: Drug prices prompt debate over ‘last resort’ options in Amsterdam

The government is about to debate pharmaceutical policies, but the session may be hijacked by concerns over prices and the overall influence of drug makers.

CVS Pharmacy unveils Black Friday, Cyber Monday deals

David SalazarCVS Pharmacy  said it will kick off a three-day Black Friday sales event on Thanksgiving Day to run through Nov. 25, and hold flash sales during the week of Cyber Monday.  read more

Startup seeking to resurrect Vioxx, arthritis drug pulled from market

Merck & Co. voluntarily pulled the blockbuster drug in 2004 amid evidence that it doubled the chances of having a heart attack or stroke.

STAT Plus: Pharmalittle: U.K. cries foul on price hikes; Roche sues Pfizer over a biosimilar

Canadian drug firm Concordia has raised the price of a thyroid drug by about 6,000 percent over the past decade.

Panion Bf Biotech Inc 1760 Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryPanion Bf Biotech Inc Panion Bf Biotech is a pharmaceutical company that conducts research and develops drugs for various therapeutic areas. The company manufactures pharmaceuticals, cosmetics, and consumer healthcare products. Its products include topical corticosteroids, cardiovascular drugs, nutritional supplements drugs, anticancer drug, antimicrobial agent, psychiatric medication, co...

STAT Plus: Effective treatments for ALS remain elusive after key clinical trial fails

An experimental ALS drug failed to improve symptoms in a large clinical trial. It was a blow to Cytokinetics, the biotech developing the drug.

Acoustic Liquid Handling Mass Spectrometry Hailed as Breakthrough Technology at European Summit

ELRIG honors Labcyte with its Technology Prize Labcyte Inc. today announced that its Echo® Acoustic Mass Spectrometry platform was awarded the Technology Prize during the European Laboratory Research & Innovation Group’s (ELRIG) annual Drug Discovery event in Liverpool, UK. The award was

FDA Moves Forward On Topical Treatment For Gorlin Syndrome

NewsFDA grants Breakthrough Therapy and Orphan Drug designations for patidegib, a topical treatment for the rare Gorlin syndrome genetic disease that causes patients to develop multiple basal cell carcinomas.

LIDDS: Patent granted in India for prostate cancer treatment

LIDDS has received approval from the Indian patent office for its patent on "Method for treatment of prostate cancer and other prostate diseases" with the NanoZolid® drug delivery technology formulation. The approved patent protects means of administering active substances to the prostate gland for high local efficacy while avoiding systemic side effects. The patent provides ...

The Path to New Drug Discoveries and Development with #Cannabis

Point Roberts, WA - November 21, 2017 (Investorideas.com Newswire) Investorideas.com, a global news source and investor resource covering cannabis and hemp stocks issues a sector news alert on companies with new drug discoveries and developments in the sector.

Fred’s, Inc. Schedules Third Quarter 2017 Earnings Announcement and Conference Call Webcast for December 6, 2017

Fred’s, Inc. (the “Company”) (NASDAQ:FRED) today announced that its third quarter 2017 results will be issued on the morning of Wednesday, December 6, 2017. The Company will host a conference call/webcast at 8:00 a.m. Eastern Time on Wednesday, December 6, 2017, to discuss third quarter 2017 results. The webcast will be available live and as...

Medical System Network Co Ltd 4350 Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryMedical System Network Co Ltd Medical System is a pharmaceutical service provider that offers services in the areas of dispensing pharmacy business, feeding business, clinical trial facility support project, visiting nursing business, pharmaceuticals business network, dispensing pharmacy, equipment leasing, and study institutional support. The company also develops, sells, and maintains dis...

UPDATE 1-Acorda Therapeutics scraps Parkinson's drug after deaths

Acorda Therapeutics Inc said on Monday it would stop developing its Parkinson's disease drug, tozadenant, less than a week after the company reported deaths in key studies testing the treatment. The company's shares, which have fallen about 40 percent since it reported deaths of five patients, were down 2.5 percent in premarket trading.

Roche’s Potential Hemophilia Blockbuster and Lung Cancer Drug Succeed in the Clinic

Roche has enjoyed a dream start to the week with both its immuno-oncology candidate, Tecentriq, and its hemophilia A drug, Hemlibra, succeeding in the clinic. Roche’s week started with a bang as two of its drug candidates achieved positive results ... This awesome article Roche’s Potential Hemophilia Blockbuster and Lung Cancer Drug Succeed in the Clinic appeared first on Labiotech.eu. Be kind...

IV drug users respond well to endophthalmitis treatment

Intravenous drug users who had endogenous endophthalmitis responded better to treatment than those who did not use drugs, according to a retrospective medical record review.The researchers said those who did not use drugs fared worse due to more chronic comorbidities and older age.Investigators chose a large medical center in New Hampshire for its patient population, as the age-related rate of dea...

Positive Results For Tecentriq-Avastin-Chemo Combo In Lung Cancer

NewsData will be submitted to health authorities globally, including the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA).

UK drug development firm RxCelerate expands in US

Contract drug developer RxCelerate has opened an office in Massachusetts to expand its medicinal chemistry, antibody discovery, and preclinical safety services throughout North America.

Cigna Customers with Connected Pharmacy and Medical Benefits Are More Active in Improving Their Health, Leading to Lower Medical Costs

Employers Save Average of $253 Annually for Each Individual Cigna Identifies for a Health Program A Cigna (NYSE: CI) study found that customers whose medical and pharmacy benefits are both administered by Cigna are more active in health coaching and case management programs than those with only medical coverage with the company. Incre...

Walgreens Earns Best Place to Work for LGBTQ Equality Recognition in 2018 Corporate Equality Index

Company scores 100 percent for the 12th year on Human Rights Campaign Foundation’s 16th Annual Scorecard Walgreens received a perfect score of 100 percent on the 2018 Corporate Equality Index (CEI), a national benchmarking survey and report on corporate policies and practices related to LGBTQ workplace equality, administered by the Human Rights Camp...

Walgreens Boots Alliance Recommends Stockholders Reject Mini-Tender Offer by TRC Capital Corporation

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced it has received notice of an unsolicited mini-tender offer by TRC Capital Corporation to purchase up to 2 million shares of Walgreens Boots Alliance common stock at a price of $67.88 per share in cash. TRC Capital’s offering price is 4.38 percent below the closing price per share of Walgreens B...

New York Institute of Career Development Welcomes Thomas Frisco to Faculty

The New York Institute of Career Development is excited to introduce Thomas Frisco to their team of mentors. NEW YORK (PRWEB) November 20, 2017 The New York Institute of Career Development is excited to introduce Thomas Frisco to their team of mentors. In addition to being an educator and licensed pharmacy technician himself, Frisco sits on many pharmacy technician school advisory boards in the s...

UK drug development firm RxCelerate expands stateside

Contract drug developer RxCelerate has opened an office in Massachusetts to expand its medicinal chemistry, antibody discovery and preclinical safety services throughout North America.

A Cancer Cell’s Weight Predicts Its Therapeutic Opponent

Scientists in the U.S. have shown how measuring changes in the weight of individual living cancer cells taken from multiple myeloma (MM) patients can accurately predict whether their cancer will respond to different drug treatments. The microfluidic device, known as a suspended microchannel resonator (SMR), is capable of weighing cells 10 to 100 times more accurately than any other existing method...

Quick Search
Advertisement
 

review and buy Pharmacy market research data and corporate reports here